Craig Hendrix is the Wellcome Professor and Director, Division of Clinical Pharmacology, at Johns Hopkins University School of Medicine. He trained in infectious diseases and clinical pharmacology at Hopkins before 10 years as an Air Force physician and 27 years at Johns Hopkins. Dr. Hendrix’s primary research focus is clinical pharmacology of HIV pre-exposure prophylaxis. He’s served as Principal Investigator of over 120 phase I clinical studies and served as the principal pharmacologist for over 140 clinical trials, primarily in the Microbicide Trials Network and HIV Prevention Trials Network. He has published over 300 scientific papers.
He greatly enjoys teaching and mentoring trainees at all levels and directs the Johns Hopkins T32 Clinical Pharmacology Training Program. He has received awards for teaching and mentoring from Johns Hopkins.
He has also served as a member of a National Academy of Medicine Advisory Panel, the CDC Board of Scientific Counselors, the board of several pharmacology professional societies, member of several FDA Advisory Committees. Currently, he is Chairman of the American Board of Clinical Pharmacology. He has received awards for scientific achievement from the PhRMA Foundation, the American College of Clinical Pharmacology, the American Society of Clinical Pharmacology and Therapeutics, and the FDA.
